Seak Hee Oh, In Sook Jeong, Dae Yeon Kim, Jung‐Man Namgoong, Won Kyoung Jhang, Seong Jong Park, Dong‐Hwan Jung, Deok Bog Moon, Gi‐Won Song, Gil‐Chun Park, Tae‐Yong Ha, Chul‐Soo Ahn, Ki‐Hun Kim, Shin Hwang, Sung Gyu Lee, Kyung Mo Kim – 17 September 2021 – Living donor liver transplantation (LDLT) is a significant advancement for the treatment of children with end‐stage liver disease given the shortage of deceased donors. The ultimate goal of pediatric LDLT is to achieve complete donor safety and zero recipient mortality.

Abu Bakar Hafeez Bhatti, Nusrat Yar Khan – 17 September 2021

Nia Adeniji, Renumathy Dhanasekaran – 16 September 2021 – Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide. Early detection of HCC enables patients to avail curative therapies that can improve patient survival. Current international guidelines advocate for the enrollment of patients at high risk for HCC, like those with cirrhosis, in surveillance programs that perform ultrasound every 6 months.

Cameron J. Fairfield, Thomas M. Drake, Riinu Pius, Andrew D. Bretherick, Archie Campbell, David W. Clark, Jonathan A. Fallowfield, Caroline Hayward, Neil C. Henderson, Peter K. Joshi, Nicholas L. Mills, David J. Porteous, Prakash Ramachandran, Robert K. Semple, Catherine A. Shaw, Cathie L.M. Sudlow, Paul R.H.J. Timmers, James F. Wilson, Stephen J. Wigmore, Ewen M. Harrison, Athina Spiliopoulou – 16 September 2021 – Genome‐wide association studies (GWAS) have identified several risk loci for nonalcoholic fatty liver disease (NAFLD).

Kuai Ma, Weitao Que, Xin Hu, Wen‐Zhi Guo, Er‐li Gu, Liang Zhong, Virginia Morello, Manuela Cazzanti, Paolo Michieli, Terumi Takahara, Xiao‐Kang Li – 15 September 2021 – Small‐for‐size syndrome (SFSS) is a common complication following partial liver transplantation and extended hepatectomy. SFSS is characterized by postoperative liver dysfunction caused by insufficient regenerative capacity and portal hyperperfusion and is more frequent in patients with preexisting liver disease.

Sarah R. Lieber, Hannah P. Kim, Luke Baldelli, Rebekah Nash, Randall Teal, Gabrielle Magee, Chirag S. Desai, Marci M. Loiselle, Simon C. Lee, Amit G. Singal, Jorge A. Marrero, A. Sidney Barritt, Donna M. Evon – 15 September 2021 – Survivorship after liver transplantation (LT) is a novel concept providing a holistic view of the arduous recovery experienced after transplantation. We explored components of early survivorship including physical, emotional, and psychological challenges to identify intervention targets for improving the recovery process of LT recipients and caregivers.

Neil Mehta, Francis Y. Yao – 15 September 2021

Fei Luo, Federico Oldoni, Avash Das – 15 September 2021 – Transmembrane 6 superfamily member 2 (TM6SF2) is located on chromosome 19 (19p12) and encodes for a protein of undetermined function. Genetic studies have reported the association between a nonsynonymous variant in TM6SF2 (E167K, rs58542926) with hepatic triglyceride content and its impact on the cardiovascular system. Clinical and epidemiological studies have confirmed the role of TM6SF2 in the development of nonalcoholic fatty liver disease (NAFLD).

Pietro Addeo, Philippe Bachellier, Vincent Noblet – 15 September 2021

Tetsuya Hosaka, Fumitaka Suzuki, Mariko Kobayashi, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada – 15 September 2021 – Serum hepatitis B core‐related antigen (HBcrAg) and surface antigen (HBsAg) are surrogate markers of intrahepatic covalently closed circular DNA. The measurement range of the current HBcrAg assay is relatively narrow.